Granules India receives EIR from USFDA for Granules OmniChem facility

06 Oct 2017 Evaluate

Granules India has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for Granules OmniChem facility. This facility was inspected by USFDA in December 2016 and there were seven observations during the inspection. This facility currently manufactures API intermediates.

Granules OmniChem is an equal Joint Venture Company (JVC) between the company and Ajinimoto OmniChem N.V., located at Vizag in state of Andhra Pradesh.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).



Granules India Share Price

560.70 16.30 (2.99%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×